October 2021 Ghana
Tomorrow Foundation's founder prides herself on her newest capital investment into mPharma, one of the fastest-growing health tech startups in Africa and ranked as the most promising digital healthcare start-up in Africa by CB Insights. mPharma was founded in Ghana by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) and has since 2013 been managing prescription drug inventory for pharmacies and their suppliers in emerging markets.
mPharma offers innovative solutions for hospitals, pharmacies and patients to address the issue of faulty inventory management and financing, and thereby improving patients' access to necessary high-quality medicine. They provide access to a network of high-quality chronic disease medicine at sustainable prices, ensuring that the shelves in the pharmacies rarely are empty. So far, more than 400,000 patients have saved money on their pharmacy bills thanks to mPharma.
With a presence in eight African countries, mPharma is the most geographically diversified healthcare provider on the continent. mPharma is now the biggest provider of 'buy, pay later' programs for the pharmaceutical industry in Africa with more than 50% of the world's 15 largest pharmaceutical companies being clients.
Apart from this, these are some of the various benevolent initiatives mPharma has launched:
The future of mPharma
One month ago, mPharma launched a digital primary care service called Mutti Doctor. Mutti Doctor steps up the game of virtual video consultations with a multi-functional medical diagnostic device that serves the purpose of being both a digital stethoscope, otoscope to examine the ear, thermometer, and also has an illuminated examination camera. The digital examinations are supported inside mPharma's mutti pharmacies by a licenced community nurse while doctors can be consulted remotely. This service increases the accessibility because it is generally located much closer to the patients' homes, finally leading to patients achieving better health outcomes.
Another major victory for the company, and for the people, is, that mPharma entered the market in Uganda by acquiring Vine Pharmacy which they intend to bring back to its former days of glory where it held the position of the biggest retail pharmacy chain in Uganda.
Going forward and re-entering the world post-COVID-19, it's mPharma's CEO, Gregory Rockson's belief that their fast-moving company also can have a major role in helping African governments emerge from the pandemic by supporting them in building a resilient public health care system.
With Tomorrow Foundation as an investor in mPharma, we are sincerely looking forward to supporting their future initiatives regarding optimizing access to high quality, affordable and timely health care in Africa, as we see this as a necessary part of the solution to successfully bridge the gap.
The team behind mPharma deserves all our humble respect for the positive impact they have on the health of African people, meanwhile still continuing to grow their revenue year by year, attracting high-profile institutional and private investors and benefitting from a top of the class board of directors.
mPharma serves as a brilliant example that social entrepreneurship can have a genuine impact on real people in need and still be profitable. With a firm hope of a brighter future, we envision that this type of company that place people before profit will drastically help shape the world of a better Tomorrow.
Read more about mPharma here: https://mpharma.com/